Skip to main content
. 2022 Oct 21;13(10):891. doi: 10.1038/s41419-022-05336-0

Fig. 1. CD206+ TAMs are correlated with poor prognosis in patients with SCLC.

Fig. 1

A Representative images of IHC staining for CD68, CD206, and NLRP6 in primary tumors and adjacent regions in patients with SCLC. Scale bar, 100 μm. B Statistical analysis of the number of CD206+ TAMs in patients with and without metastatic SCLC (N = 36). C Statistical analysis of NLRP6 IHC score in CD206high and CD206low patients with SCLC (N = 36). D Survival analysis of patients with SCLC based on CD206 expression levels (N = 36). Bar graphs show the mean ± SEM; *P < 0.05, ***P < 0.001. TAMs tumor-associated macrophages, SCLC small cell lung cancer, IHC immunohistochemistry, SEM standard error of mean.